The Fiscal Year 2015 (FY15) Defense Appropriations Act provides $16 million (M) to the Department of Defense Neurotoxin Exposure Treatment Parkinson’s Research (NETPR) Program to provide support for research of exceptional scientific merit leading to an understanding of the cause, prevention, and treatment of the loss of dopaminergic neurons in the Substantia nigra that result in Parkinson’s disease (PD). Applications to the FY15 NETPR Program will be solicited by the U.S. Army Medical Research Acquisition Activity (USAMRAA). The executing agent for the anticipated Program Announcements/Funding Opportunities is the Congressionally Directed Medical Research Programs (CDMRP).
Showing posts with label CDMRP. Show all posts
Showing posts with label CDMRP. Show all posts
Monday, 12 October 2015
Neurotoxin Exposure Treatment Parkinson's Research Program Pre-announcement (UNCLASSIFIED)
The Fiscal Year 2015 (FY15) Defense Appropriations Act provides $16 million (M) to the Department of Defense Neurotoxin Exposure Treatment Parkinson’s Research (NETPR) Program to provide support for research of exceptional scientific merit leading to an understanding of the cause, prevention, and treatment of the loss of dopaminergic neurons in the Substantia nigra that result in Parkinson’s disease (PD). Applications to the FY15 NETPR Program will be solicited by the U.S. Army Medical Research Acquisition Activity (USAMRAA). The executing agent for the anticipated Program Announcements/Funding Opportunities is the Congressionally Directed Medical Research Programs (CDMRP).
Subscribe to:
Posts (Atom)